4//SEC Filing
Grund Nicholas 4
Accession 0001562180-24-000983
CIK 0001517022other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:11 PM ET
Size
7.7 KB
Accession
0001562180-24-000983
Insider Transaction Report
Form 4
Grund Nicholas
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-01-31+303,300→ 303,300 total - Award
Stock Option (Right to buy)
2024-01-31+454,950→ 454,950 totalExercise: $1.68Exp: 2034-01-31→ Common Stock (454,950 underlying)
Footnotes (2)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F2]The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001661887
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:11 PM ET
- Size
- 7.7 KB